These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 24589565)
1. Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene. Berge KE; Retterstøl K; Romeo S; Pirazzi C; Leren TP Atherosclerosis; 2014 May; 234(1):30-3. PubMed ID: 24589565 [TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia. Chokshi N; Blumenschein SD; Ahmad Z; Garg A J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350 [TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene. Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123 [TBL] [Abstract][Full Text] [Related]
4. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome. Paquette M; Hegele RA; Paré G; Baass A J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency. Okubo M; Toromanovic A; Ebara T; Murase T Clin Chim Acta; 2015 Jan; 438():148-53. PubMed ID: 25172036 [TBL] [Abstract][Full Text] [Related]
6. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778 [TBL] [Abstract][Full Text] [Related]
7. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554 [TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148 [TBL] [Abstract][Full Text] [Related]
9. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis. Ariza MJ; Martínez-Hernández PL; Ibarretxe D; Rabacchi C; Rioja J; Grande-Aragón C; Plana N; Tarugi P; Olivecrona G; Calandra S; Valdivielso P J Clin Lipidol; 2016; 10(1):92-100.e1. PubMed ID: 26892125 [TBL] [Abstract][Full Text] [Related]
10. A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene. Buonuomo PS; Bartuli A; Rabacchi C; Bertolini S; Calandra S J Clin Lipidol; 2015; 9(2):265-70. PubMed ID: 25911085 [TBL] [Abstract][Full Text] [Related]
12. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report. Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710 [TBL] [Abstract][Full Text] [Related]